Fundraising Fox
Maplightrx
154 employees on LinkedIn · 3 known investors
Find your way into Maplightrx
Sign up to see every warm intro you have to Maplightrx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Maplightrx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MapLight develops neurological and neuropsychiatric drug therapies using a discovery platform that identifies neural circuits linked to disease for targeted treatment of conditions like schizophrenia, Alzheimer's disease psychosis, and autism spectrum disorder.
Founders & leadership
CK
Christopher Kroeger, M.D.Chief Executive Officer, Founder, Board Member
KD
Karl Deisseroth, M.D., Ph.D.Founder, Scientific Advisory Board
RM
Robert Malenka, M.D., Ph.D.Founder, Board Member, Scientific Advisory Board
CK
Christopher KroegerFounder
KD
Karl DeisserothFounder
KN
Karoly NikolichFounder
RM
Robert MalenkaFounder
Investors · 3
Frequently asked questions
- What does Maplightrx do?
- MapLight develops neurological and neuropsychiatric drug therapies using a discovery platform that identifies neural circuits linked to disease for targeted treatment of conditions like schizophrenia, Alzheimer's disease psychosis, and autism spectrum disorder.
- Who founded Maplightrx?
- Maplightrx was founded by Christopher Kroeger, M.D., Karl Deisseroth, M.D., Ph.D., Robert Malenka, M.D., Ph.D..
- Who are Maplightrx's investors?
- Maplightrx's investors include Avego BioScience Capital, Forbion, Pivotal Life Sciences.